APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cone-rod Dystrophy Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cone-rod Dystrophy Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025194 pages

Choose your research edition.

Industry ResearchCone-rod Dystrophy Treatment Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Cone-rod Dystrophy Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cone-rod Dystrophy Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cone-rod Dystrophy Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cone-rod Dystrophy Treatment Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Global Cone-rod Dystrophy Treatment includes JCyte, Nanoscope Therapeutics, SparingVision, MeiraGTx, AGTC, Biogen, etc. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific.

Report Includes

This report provides an overview of the global Cone-rod Dystrophy Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Cone-rod Dystrophy Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cone-rod Dystrophy Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cone-rod Dystrophy Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Cone-rod Dystrophy Treatment Segment by Company

JCyte

Nanoscope Therapeutics

SparingVision

MeiraGTx

AGTC

Biogen

Second Sight Medical

GlaxoSmithKline

Johnson And Johnson

Sanofi

Pfizer

Novartis

Abbott Laboratories

Cone-rod Dystrophy Treatment Segment by Type

Gene Therapy

Stem Cell Therapy

Retinal Implant Surgery

Cone-rod Dystrophy Treatment Segment by Application

Hospital

Ophthalmology Department

Other

Cone-rod Dystrophy Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cone-rod Dystrophy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cone-rod Dystrophy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cone-rod Dystrophy Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cone-rod Dystrophy Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cone-rod Dystrophy Treatment industry.

Chapter 3: Detailed analysis of Cone-rod Dystrophy Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cone-rod Dystrophy Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Gene Therapy Table 3. Key Players of Stem Cell Therapy Table 4. Key Players of Retinal Implant Surgery Table 4. Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Ophthalmology Department Table 7. Key Players of Other Table 8. Global Cone-rod Dystrophy Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Cone-rod Dystrophy Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Cone-rod Dystrophy Treatment Market Share by Region (2021-2026) Table 11. Global Cone-rod Dystrophy Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Cone-rod Dystrophy Treatment Market Share by Region (2027-2032) Table 13. Cone-rod Dystrophy Treatment Industry Trends Table 14. Cone-rod Dystrophy Treatment Industry Drivers Table 15. Cone-rod Dystrophy Treatment Industry Opportunities and Challenges Table 16. Cone-rod Dystrophy Treatment Industry Restraints Table 17. Global Cone-rod Dystrophy Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Cone-rod Dystrophy Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Cone-rod Dystrophy Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cone-rod Dystrophy Treatment Key Company Head Office and Area Served Table 21. Global Cone-rod Dystrophy Treatment Company, Product Type & Application Table 22. Global Cone-rod Dystrophy Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Cone-rod Dystrophy Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Cone-rod Dystrophy Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cone-rod Dystrophy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Cone-rod Dystrophy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Cone-rod Dystrophy Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Cone-rod Dystrophy Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Cone-rod Dystrophy Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cone-rod Dystrophy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Cone-rod Dystrophy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Cone-rod Dystrophy Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Cone-rod Dystrophy Treatment Revenue Market Share by Application (2027-2032) Table 35. JCyte Company Information Table 36. JCyte Business Overview Table 37. JCyte Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. JCyte Cone-rod Dystrophy Treatment Product Portfolio Table 39. JCyte Recent Development Table 40. Nanoscope Therapeutics Company Information Table 41. Nanoscope Therapeutics Business Overview Table 42. Nanoscope Therapeutics Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Nanoscope Therapeutics Cone-rod Dystrophy Treatment Product Portfolio Table 44. Nanoscope Therapeutics Recent Development Table 45. SparingVision Company Information Table 46. SparingVision Business Overview Table 47. SparingVision Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. SparingVision Cone-rod Dystrophy Treatment Product Portfolio Table 49. SparingVision Recent Development Table 50. MeiraGTx Company Information Table 51. MeiraGTx Business Overview Table 52. MeiraGTx Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. MeiraGTx Cone-rod Dystrophy Treatment Product Portfolio Table 54. MeiraGTx Recent Development Table 55. AGTC Company Information Table 56. AGTC Business Overview Table 57. AGTC Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. AGTC Cone-rod Dystrophy Treatment Product Portfolio Table 59. AGTC Recent Development Table 60. Biogen Company Information Table 61. Biogen Business Overview Table 62. Biogen Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Biogen Cone-rod Dystrophy Treatment Product Portfolio Table 64. Biogen Recent Development Table 65. Second Sight Medical Company Information Table 66. Second Sight Medical Business Overview Table 67. Second Sight Medical Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Second Sight Medical Cone-rod Dystrophy Treatment Product Portfolio Table 69. Second Sight Medical Recent Development Table 70. GlaxoSmithKline Company Information Table 71. GlaxoSmithKline Business Overview Table 72. GlaxoSmithKline Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. GlaxoSmithKline Cone-rod Dystrophy Treatment Product Portfolio Table 74. GlaxoSmithKline Recent Development Table 75. Johnson And Johnson Company Information Table 76. Johnson And Johnson Business Overview Table 77. Johnson And Johnson Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Johnson And Johnson Cone-rod Dystrophy Treatment Product Portfolio Table 79. Johnson And Johnson Recent Development Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Sanofi Cone-rod Dystrophy Treatment Product Portfolio Table 84. Sanofi Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Pfizer Cone-rod Dystrophy Treatment Product Portfolio Table 89. Pfizer Recent Development Table 90. Novartis Company Information Table 91. Novartis Business Overview Table 92. Novartis Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Novartis Cone-rod Dystrophy Treatment Product Portfolio Table 94. Novartis Recent Development Table 95. Abbott Laboratories Company Information Table 96. Abbott Laboratories Business Overview Table 97. Abbott Laboratories Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Abbott Laboratories Cone-rod Dystrophy Treatment Product Portfolio Table 99. Abbott Laboratories Recent Development Table 100. North America Cone-rod Dystrophy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 101. North America Cone-rod Dystrophy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 102. North America Cone-rod Dystrophy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 103. North America Cone-rod Dystrophy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 104. North America Cone-rod Dystrophy Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Cone-rod Dystrophy Treatment Market Size by Country (2021-2026) Table 106. North America Cone-rod Dystrophy Treatment Market Size by Country (2027-2032) Table 107. Europe Cone-rod Dystrophy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 108. Europe Cone-rod Dystrophy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 109. Europe Cone-rod Dystrophy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 110. Europe Cone-rod Dystrophy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 111. Europe Cone-rod Dystrophy Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Cone-rod Dystrophy Treatment Market Size by Country (2021-2026) Table 113. Europe Cone-rod Dystrophy Treatment Market Size by Country (2027-2032) Table 114. China Cone-rod Dystrophy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 115. China Cone-rod Dystrophy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 116. China Cone-rod Dystrophy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 117. China Cone-rod Dystrophy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia Cone-rod Dystrophy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 119. Asia Cone-rod Dystrophy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 120. Asia Cone-rod Dystrophy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 121. Asia Cone-rod Dystrophy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia Cone-rod Dystrophy Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Cone-rod Dystrophy Treatment Market Size by Country (2021-2026) Table 124. Asia Cone-rod Dystrophy Treatment Market Size by Country (2027-2032) Table 125. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Type (2021-2026) & (US$ Million) Table 126. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Type (2027-2032) & (US$ Million) Table 127. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Application (2021-2026) & (US$ Million) Table 128. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Application (2027-2032) & (US$ Million) Table 129. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (2021-2026) Table 131. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Cone-rod Dystrophy Treatment Product Image Figure 2. Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cone-rod Dystrophy Treatment Market Share by Type: 2025 VS 2032 Figure 4. Gene Therapy Image Figure 5. Stem Cell Therapy Image Figure 6. Retinal Implant Surgery Image Figure 7. Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Cone-rod Dystrophy Treatment Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Ophthalmology Department Image Figure 11. Other Image Figure 12. Global Cone-rod Dystrophy Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global Cone-rod Dystrophy Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Cone-rod Dystrophy Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Cone-rod Dystrophy Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cone-rod Dystrophy Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cone-rod Dystrophy Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Cone-rod Dystrophy Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Cone-rod Dystrophy Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America Cone-rod Dystrophy Treatment Market Share by Type (2021-2032) Figure 25. North America Cone-rod Dystrophy Treatment Market Share by Application (2021-2032) Figure 26. North America Cone-rod Dystrophy Treatment Market Share by Country (2021-2032) Figure 27. United States Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Cone-rod Dystrophy Treatment Market Share by Type (2021-2032) Figure 32. Europe Cone-rod Dystrophy Treatment Market Share by Application (2021-2032) Figure 33. Europe Cone-rod Dystrophy Treatment Market Share by Country (2021-2032) Figure 34. Germany Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Cone-rod Dystrophy Treatment Market Share by Type (2021-2032) Figure 42. China Cone-rod Dystrophy Treatment Market Share by Application (2021-2032) Figure 43. Asia Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia Cone-rod Dystrophy Treatment Market Share by Type (2021-2032) Figure 45. Asia Cone-rod Dystrophy Treatment Market Share by Application (2021-2032) Figure 46. Asia Cone-rod Dystrophy Treatment Market Share by Country (2021-2032) Figure 47. Japan Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Share by Country (2021-2032) Figure 57. Brazil Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile Cone-rod Dystrophy Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Stem Cell Therapy
  • Retinal Implant Surgery
Applications
  • Hospital
  • Ophthalmology Department
  • Other
Companies covered
  • JCyte
  • Nanoscope Therapeutics
  • SparingVision
  • MeiraGTx
  • AGTC
  • Biogen
  • Second Sight Medical
  • GlaxoSmithKline
  • Johnson And Johnson
  • Sanofi
  • Pfizer
  • Novartis
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Therapy
  5. 1.2.3 Stem Cell Therapy
  6. 1.2.4 Retinal Implant Surgery
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Cone-rod Dystrophy Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Ophthalmology Department
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Cone-rod Dystrophy Treatment Growth Trends by Region
  14. 1.5.1 Global Cone-rod Dystrophy Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Cone-rod Dystrophy Treatment Market Size by Region (2021-2026)
  16. 1.5.3 Cone-rod Dystrophy Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Cone-rod Dystrophy Treatment Market Dynamics
  1. 2.1 Cone-rod Dystrophy Treatment Industry Trends
  2. 2.2 Cone-rod Dystrophy Treatment Industry Drivers
  3. 2.3 Cone-rod Dystrophy Treatment Industry Opportunities and Challenges
  4. 2.4 Cone-rod Dystrophy Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cone-rod Dystrophy Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Cone-rod Dystrophy Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cone-rod Dystrophy Treatment Key Company Head office and Area Served
  4. 3.4 Global Cone-rod Dystrophy Treatment Company, Product Type & Application
  5. 3.5 Global Cone-rod Dystrophy Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cone-rod Dystrophy Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cone-rod Dystrophy Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cone-rod Dystrophy Treatment Tier 1, Tier 2, and Tier 3
4 Cone-rod Dystrophy Treatment Market by Type
  1. 4.1 Global Cone-rod Dystrophy Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cone-rod Dystrophy Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Cone-rod Dystrophy Treatment Market Size Share by Type (2021-2032)
5 Cone-rod Dystrophy Treatment Market by Application
  1. 5.1 Global Cone-rod Dystrophy Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cone-rod Dystrophy Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Cone-rod Dystrophy Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 JCyte
  2. 6.1.1 JCyte Company Information
  3. 6.1.2 JCyte Business Overview
  4. 6.1.3 JCyte Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 JCyte Cone-rod Dystrophy Treatment Product Portfolio
  6. 6.1.5 JCyte Recent Developments
  7. 6.2 Nanoscope Therapeutics
  8. 6.2.1 Nanoscope Therapeutics Company Information
  9. 6.2.2 Nanoscope Therapeutics Business Overview
  10. 6.2.3 Nanoscope Therapeutics Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Nanoscope Therapeutics Cone-rod Dystrophy Treatment Product Portfolio
  12. 6.2.5 Nanoscope Therapeutics Recent Developments
  13. 6.3 SparingVision
  14. 6.3.1 SparingVision Company Information
  15. 6.3.2 SparingVision Business Overview
  16. 6.3.3 SparingVision Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 SparingVision Cone-rod Dystrophy Treatment Product Portfolio
  18. 6.3.5 SparingVision Recent Developments
  19. 6.4 MeiraGTx
  20. 6.4.1 MeiraGTx Company Information
  21. 6.4.2 MeiraGTx Business Overview
  22. 6.4.3 MeiraGTx Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 MeiraGTx Cone-rod Dystrophy Treatment Product Portfolio
  24. 6.4.5 MeiraGTx Recent Developments
  25. 6.5 AGTC
  26. 6.5.1 AGTC Company Information
  27. 6.5.2 AGTC Business Overview
  28. 6.5.3 AGTC Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 AGTC Cone-rod Dystrophy Treatment Product Portfolio
  30. 6.5.5 AGTC Recent Developments
  31. 6.6 Biogen
  32. 6.6.1 Biogen Company Information
  33. 6.6.2 Biogen Business Overview
  34. 6.6.3 Biogen Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Biogen Cone-rod Dystrophy Treatment Product Portfolio
  36. 6.6.5 Biogen Recent Developments
  37. 6.7 Second Sight Medical
  38. 6.7.1 Second Sight Medical Company Information
  39. 6.7.2 Second Sight Medical Business Overview
  40. 6.7.3 Second Sight Medical Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Second Sight Medical Cone-rod Dystrophy Treatment Product Portfolio
  42. 6.7.5 Second Sight Medical Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GlaxoSmithKline Cone-rod Dystrophy Treatment Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Johnson And Johnson
  50. 6.9.1 Johnson And Johnson Company Information
  51. 6.9.2 Johnson And Johnson Business Overview
  52. 6.9.3 Johnson And Johnson Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Johnson And Johnson Cone-rod Dystrophy Treatment Product Portfolio
  54. 6.9.5 Johnson And Johnson Recent Developments
  55. 6.10 Sanofi
  56. 6.10.1 Sanofi Company Information
  57. 6.10.2 Sanofi Business Overview
  58. 6.10.3 Sanofi Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sanofi Cone-rod Dystrophy Treatment Product Portfolio
  60. 6.10.5 Sanofi Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Pfizer Cone-rod Dystrophy Treatment Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Novartis
  68. 6.12.1 Novartis Company Information
  69. 6.12.2 Novartis Business Overview
  70. 6.12.3 Novartis Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Novartis Cone-rod Dystrophy Treatment Product Portfolio
  72. 6.12.5 Novartis Recent Developments
  73. 6.13 Abbott Laboratories
  74. 6.13.1 Abbott Laboratories Company Information
  75. 6.13.2 Abbott Laboratories Business Overview
  76. 6.13.3 Abbott Laboratories Cone-rod Dystrophy Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Abbott Laboratories Cone-rod Dystrophy Treatment Product Portfolio
  78. 6.13.5 Abbott Laboratories Recent Developments
7 North America
  1. 7.1 North America Cone-rod Dystrophy Treatment Market Size (2021-2032)
  2. 7.2 North America Cone-rod Dystrophy Treatment Market Size by Type
  3. 7.2.1 North America Cone-rod Dystrophy Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Cone-rod Dystrophy Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Cone-rod Dystrophy Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Cone-rod Dystrophy Treatment Market Size by Application
  7. 7.3.1 North America Cone-rod Dystrophy Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Cone-rod Dystrophy Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Cone-rod Dystrophy Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Cone-rod Dystrophy Treatment Market Size by Country
  11. 7.4.1 North America Cone-rod Dystrophy Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cone-rod Dystrophy Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Cone-rod Dystrophy Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Cone-rod Dystrophy Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cone-rod Dystrophy Treatment Market Size (2021-2032)
  2. 8.2 Europe Cone-rod Dystrophy Treatment Market Size by Type
  3. 8.2.1 Europe Cone-rod Dystrophy Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cone-rod Dystrophy Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cone-rod Dystrophy Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Cone-rod Dystrophy Treatment Market Size by Application
  7. 8.3.1 Europe Cone-rod Dystrophy Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cone-rod Dystrophy Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cone-rod Dystrophy Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Cone-rod Dystrophy Treatment Market Size by Country
  11. 8.4.1 Europe Cone-rod Dystrophy Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cone-rod Dystrophy Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cone-rod Dystrophy Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cone-rod Dystrophy Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cone-rod Dystrophy Treatment Market Size (2021-2032)
  2. 9.2 China Cone-rod Dystrophy Treatment Market Size by Type
  3. 9.2.1 China Cone-rod Dystrophy Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Cone-rod Dystrophy Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Cone-rod Dystrophy Treatment Market Share by Type (2021-2032)
  6. 9.3 China Cone-rod Dystrophy Treatment Market Size by Application
  7. 9.3.1 China Cone-rod Dystrophy Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Cone-rod Dystrophy Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Cone-rod Dystrophy Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cone-rod Dystrophy Treatment Market Size (2021-2032)
  2. 10.2 Asia Cone-rod Dystrophy Treatment Market Size by Type
  3. 10.2.1 Asia Cone-rod Dystrophy Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cone-rod Dystrophy Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cone-rod Dystrophy Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Cone-rod Dystrophy Treatment Market Size by Application
  7. 10.3.1 Asia Cone-rod Dystrophy Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cone-rod Dystrophy Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cone-rod Dystrophy Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Cone-rod Dystrophy Treatment Market Size by Country
  11. 10.4.1 Asia Cone-rod Dystrophy Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cone-rod Dystrophy Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cone-rod Dystrophy Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cone-rod Dystrophy Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cone-rod Dystrophy Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst